Mark DiSiena
Equibles does not estimate personal net worth.
Get an email with a short summary when DataMeds AI, Inc. publishes a filing, an earnings call transcript or a press release.
Get MEDS alertsAbout Mark DiSiena
Mark DiSiena is recorded as CFO at DataMeds AI, Inc. (MEDS) since April 22, 2025. DataMeds AI, Inc. reported in an 8-K filed October 10, 2025 that Mark DiSiena resigned as Chief Financial Officer, effective October 6, 2025. DataMeds AI, Inc. reported in an 8-K filed April 24, 2025 that Mark DiSiena was appointed Chief Financial Officer, effective April 22, 2025. DataMeds AI, Inc. is classified in the Medical Distribution industry within the Healthcare sector. Other leadership on record at DataMeds AI, Inc. includes Brian Norton (CEO), Gerald Commissiong (CEO), Eric Sherb (CFO) and 5 others.
“On October 6, 2025, Mark DiSiena advised the Company that he was resigning from his position as Chief Financial Officer of the Corporation effective Monday, October 6, 2025, at 5:00 p.m. EST.”
“On April 22, 2025, the Board of Directors of Wellgistics Health, Inc. (the "Company") appointed Mark DiSiena as Chief Financial Officer of the Company, effective as of April 22, 2025 (the "Commencement Date").”
Affiliation history
-
Current
2025-04-22–present
-
2025-04-22–2025-10-06
Company network
Leadership on record at DataMeds AI, Inc.
- Brian Norton CEO
- Gerald Commissiong CEO
- Eric Sherb CFO
- Donald Fell Board Member
- Gary Herman Board Member
- Howard Doss Board Member
- Michael L. Peterson Board Member
- Steven D. Lee Board Member